Semax corrects brain dysfunction caused by prenatal introduction of valproic acid

Dokl Biol Sci. 2013 May:450:126-9. doi: 10.1134/S0012496613030046. Epub 2013 Jul 3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / analogs & derivatives*
  • Adrenocorticotropic Hormone / pharmacology
  • Animals
  • Animals, Newborn
  • Anticonvulsants / adverse effects*
  • Anticonvulsants / pharmacology
  • Brain Diseases* / chemically induced
  • Brain Diseases* / drug therapy
  • Brain Diseases* / pathology
  • Brain Diseases* / physiopathology
  • Female
  • Male
  • Neuroprotective Agents / pharmacology*
  • Peptide Fragments / pharmacology*
  • Pregnancy
  • Prenatal Exposure Delayed Effects* / chemically induced
  • Prenatal Exposure Delayed Effects* / drug therapy
  • Prenatal Exposure Delayed Effects* / pathology
  • Prenatal Exposure Delayed Effects* / physiopathology
  • Rats
  • Valproic Acid / adverse effects*
  • Valproic Acid / pharmacology

Substances

  • Anticonvulsants
  • Neuroprotective Agents
  • Peptide Fragments
  • Valproic Acid
  • ACTH (4-7), Pro-Gly-Pro-
  • Adrenocorticotropic Hormone